Asambly Chemicals Co. Ltd.

Home
Products
About Us
Factory Tour
Quality Control
Contact Us
Request A Quote
News
Home ProductsActive Pharmaceutical Ingredients

Edaravone CAS 9 25 8 5 - Methyl - 2 - Phenyl - 4H - Pyrazol - 3 - One

I'm Online Chat Now

Edaravone CAS 9 25 8 5 - Methyl - 2 - Phenyl - 4H - Pyrazol - 3 - One

China Edaravone CAS 9 25 8  5 - Methyl - 2 - Phenyl - 4H - Pyrazol - 3 - One supplier

Large Image :  Edaravone CAS 9 25 8 5 - Methyl - 2 - Phenyl - 4H - Pyrazol - 3 - One

Product Details:

Place of Origin: China
Certification: GMP condition

Payment & Shipping Terms:

Minimum Order Quantity: 1KG
Packaging Details: Drum
Contact Now
Detailed Product Description
Name: Edaravone Chemical Name: 5 - Methyl - 2 - Phenyl - 4H - Pyrzol - 3 - One
CAS: 89-25-8 Molecular Formula: C10H10N2O
High Light:

668270 12 0

,

274693 27 5

Edaravone CAS : 89-25-8 5 - Methyl - 2 - phenyl - 4H - pyrazol - 3 - one

 

Name : Edaravone

 

Synonym : MCI-186

 

CAS No . : 89-25-8

 

Chemical Name : 5 - Methyl - 2 - phenyl - 4H - pyrazol - 3 - one ; 3 - metyl - 1 - phenyl - 2 - pyrazolin - 5 - one

 

Molecular Formula : C10H10N2O

 

Molecular Weight : 174.2

 

Description :

 

Edaravone is the active pharmaceutical ingredient of the brand drug names Radicava and Radicut. It belongs to the drug class miscellaneous central nervous system agent and  is used to treat Amyotrophic Lateral Sclerosis ( ALS ). It is an antioxidant. Oxidative stress is might to be part of the process kills neurons in people with amyotrophic lateral sclerosis. It is also used to help recovery form stroke in Japan. 

 

In late 1980s free radical scavenger edaravone was first developed to treat stroke to prevent the swelling of the brain. Mitsubishi Pharma marketed it in 2001 in Japan. Mitsubishi Tanabe started phase III clnical trial for amyotrophic lateral sclerosis ( ALS ) in 2011. Japan approved this use in 2015. FDA and EU granted the company the Orphan Drug Designation for edaravone in 2016. US FDA approved it to treat ALS in May 2017.

 

 

The drug might be protected by patents in some courtires or areas. We only sell it to non patent protected countries or areas. The sale to patent protection countries and areas is only for R & D purpose. The buyers should take all responsiblity of patent status in his countries or areas.

 

 

Competitive Advantage: Produced under cGMP conditions, support customers’ registrations, Approved by many esteemed companies.

Contact Details
Asambly Chemicals Co. Ltd.

Contact Person: MAO Xiaolong

Send your inquiry directly to us (0 / 3000)